Prostate cancer after exogenous testosterone treatment for impotence

Journal of Urology

Volumn 157, Issue 5, 1997, Pages 1845-

  Loughlin, K R ^a   Richie, J P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

hypogonadism; impotence; prostate; testosterone

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; ARTICLE; CANCER RISK; CASE REPORT; HORMONAL THERAPY; HUMAN; HYPOGONADISM; IMPOTENCE; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RISK ASSESSMENT; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0030899378     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64881-X     Document Type: Article

References (6)

1. Loughlin K.R. O'Leary M.P. Re: Oral androgens in the treatment of hypogonadal impotent men. Letter to the Editor J. Urol. 153 1995 1645
2. Morales A. Johnston B. Heaton J.W.P. Clark A. Oral androgens in the treatment of hypogonadal impotent men J. Urol. 152 1994 1115
3. McClure R.D. Oses R. Ernest M.L. Hypogonadal impotence treated by transdermal testosterone Urology 37 1991 224
4. Cunningham G.R. Cordero E. Thornby J.I. Testosterone replacement with transdermal therapeutic systems. Physiological serum testosterone and elevated dihydrotestosterone levels J.A.M.A. 261 1989 2525
5. Foreman J. Male menopause: much ado about not much? Boston Globe 35 October 25, 1993 31
6. Jackson J.A. Waxman J. Spiekerman A.M. Prostatic complications of testosterone replacement therapy Arch. Intern. Med. 149 1989 2365